3 Key Factors Pushing an Early Coronavirus Vaccine Breakthrough

  • Coronavirus vaccines can be produced before the projected 18 months, scientists say.
  • In the U.K., Oxford researchers injecting the first vaccines in humans said a vaccine could come by September.
  • The U.K., South Korea, China, the U.S., Switzerland, and Germany are prioritizing vaccine testing.

The expectations for a coronavirus vaccine has waned in the past several weeks, following Dr. Anthony Fauci’s firm statement that it is unlikely to arrive in the next 12 to 18 months. But, three key factors indicate that there is a possibility vaccines can be produced sooner than projected.

The three factors that could push for faster vaccine production are: Germany’s approval of human testing, at least five major countries prioritizing the creation of vaccines, and several major conglomerates exploring alternative coronavirus vaccine types.

Europe leads in coronavirus vaccine testing

On April 23, the government of Germany officially approved human testing of a coronavirus vaccine developed by a local biotech company called BioNTech.

According to German vaccines regulator the Paul Ehrlich Institut, the testing of coronavirus vaccine will be conducted on 200 healthy individuals.

German coronavirus vaccines enter human testing phase | Source: DW

When the vaccine enters a human body, it leads cells to generate antigen proteins. The proteins then protect the body against coronavirus particles as the immune system develops a countermeasure.

Whether the vaccines would work on the majority of people and not show major side effects for children are two unknown variables. A study released by the Official Journal of the American Academy of Pediatrics in 2014 found that side effects of childhood vaccines are rare.

If vaccines generally have a low probability of triggering major side effects on children, it would pave a safer path forward for coronavirus vaccine production.

Major countries are starting to test vaccines

Hong Kong, the U.S., the U.K., China, Switzerland, South…

Source Link